Original Source(s)
Related Content
Can Endotoxin-Targeted Care Improve Sepsis Outcomes?
Biomarker-guided patient selection may help identify patients with sepsis who could benefit from endotoxin-targeted therapy, although confirmatory evidence is still needed.
July 20, 2026
-
3 min
Head-to-Head Trial in Relapsing MS
The phase 3 OVERLORD-MS trial compared 2 anti-CD20 therapies in previously untreated adults with newly diagnosed relapsing multiple sclerosis and recent inflammatory disease activity.
July 7, 2026
-
6 min
Top 10 FDA Recalls Physicians Should Know
A structured overview of recent FDA recalls, corrections, and alerts involving medications, ventilators, insulin delivery systems, cardiovascular devices, anesthesia products, and other equipment used in clinical practice.
June 18, 2026
-
5 min
